Literature DB >> 35150242

Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All.

Padhmanand Sudhakar1, Dahham Alsoud1, Judith Wellens1, Sare Verstockt1, Kaline Arnauts1, Bram Verstockt1,2, Severine Vermeire1,2.   

Abstract

Inflammatory bowel disease [IBD] has a multifactorial origin and originates from a complex interplay of environmental factors with the innate immune system at the intestinal epithelial interface in a genetically susceptible individual. All these factors make its aetiology intricate and largely unknown. Multi-omic datasets obtained from IBD patients are required to gain further insights into IBD biology. We here review the landscape of multi-omic data availability in IBD and identify barriers and gaps for future research. We also outline the various technical and non-technical factors that influence the utility and interpretability of multi-omic datasets and thereby the study design of any research project generating such datasets. Coordinated generation of multi-omic datasets and their systemic integration with clinical phenotypes and environmental exposures will not only enhance understanding of the fundamental mechanisms of IBD but also improve therapeutic strategies. Finally, we provide recommendations to enable and facilitate generation of multi-omic datasets.
© The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.

Entities:  

Keywords:  -omic datasets; IBD complexity; collaborative research; coordinated funding; exposome; sparsity; strategies tailored to IBD; validation

Mesh:

Year:  2022        PMID: 35150242      PMCID: PMC9426669          DOI: 10.1093/ecco-jcc/jjac027

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   10.020


  122 in total

1.  Immunogenicity to infliximab is associated with HLA-DRB1.

Authors:  Thomas Billiet; Niels Vande Casteele; Thomas Van Stappen; Fred Princen; Sharat Singh; Ann Gils; Marc Ferrante; Gert Van Assche; Isabelle Cleynen; Severine Vermeire
Journal:  Gut       Date:  2015-04-15       Impact factor: 23.059

2.  Integrated analysis of microbe-host interactions in Crohn's disease reveals potential mechanisms of microbial proteins on host gene expression.

Authors:  Padhmanand Sudhakar; Tahila Andrighetti; Sare Verstockt; Clara Caenepeel; Marc Ferrante; João Sabino; Bram Verstockt; Severine Vermeire
Journal:  iScience       Date:  2022-02-22

3.  Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy.

Authors:  Hang Thi Thu Nguyen; Guillaume Dalmasso; Stefan Müller; Jessica Carrière; Frank Seibold; Arlette Darfeuille-Michaud
Journal:  Gastroenterology       Date:  2013-10-19       Impact factor: 22.682

4.  Systems analysis of inflammatory bowel disease based on comprehensive gene information.

Authors:  Satoru Suzuki; Takako Takai-Igarashi; Yutaka Fukuoka; Dennis P Wall; Hiroshi Tanaka; Peter J Tonellato
Journal:  BMC Med Genet       Date:  2012-04-05       Impact factor: 2.103

5.  A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer.

Authors:  Francesca Vitali; Laurie D Cohen; Andrea Demartini; Angela Amato; Vincenzo Eterno; Alberto Zambelli; Riccardo Bellazzi
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

6.  Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's Disease.

Authors:  Ryan W Stidham; Jing Wu; Jiaqi Shi; David M Lubman; Peter D R Higgins
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

7.  A Convergent Study of Genetic Variants Associated With Crohn's Disease: Evidence From GWAS, Gene Expression, Methylation, eQTL and TWAS.

Authors:  Yulin Dai; Guangsheng Pei; Zhongming Zhao; Peilin Jia
Journal:  Front Genet       Date:  2019-04-09       Impact factor: 4.599

8.  Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis.

Authors:  Lluís Revilla; Aida Mayorgas; Ana M Corraliza; Maria C Masamunt; Amira Metwaly; Dirk Haller; Eva Tristán; Anna Carrasco; Maria Esteve; Julian Panés; Elena Ricart; Juan J Lozano; Azucena Salas
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

9.  Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study.

Authors:  Laura Mühl; Emily Becker; Tanja M Müller; Raja Atreya; Imke Atreya; Markus F Neurath; Sebastian Zundler
Journal:  BMC Gastroenterol       Date:  2021-01-22       Impact factor: 3.067

10.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  1 in total

Review 1.  Precision medicine: how multiomics will shape the future of inflammatory bowel disease?

Authors:  Nienke Z Borren; Ashwin N Ananthakrishnan
Journal:  Curr Opin Gastroenterol       Date:  2022-07-01       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.